ITMCTR2200006679招募中1 期
A Randomized, controlled clinical observation of acupuncture in the treatment of psychogenic erectile dysfunction (liver-depression and kidney-deficiency type)
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 20 至 50（—）
- 性别
- Male
入选标准
- •1.Those who meet the psychogenic ED diagnostic criteria.
- •2.Those who meet the criteria for the identification of liver depression and kidney deficiency in Chinese medicine.
- •3.8=IIEF-5=21.
- •4.20-50 years old male.
- •5.Have a regular sexual partner and a stable sex life, and ensure sex life=1 time/week during treatment.
- •6.Accept and sign the informed consent form.
排除标准
- •1.Patients with drug-related ED or organic ED.
- •2.Patients with abnormalities of the genitourinary system.
- •3.Patients with genitourinary infections.
- •4.Patients with neurological disorders or serious organic diseases.
- •5.SAS > 69 or SDS > 72 or unable to guarantee discontinuation of anti-anxiety or depression medication during the trial.
- •6.Patients with coagulation disorders.
- •7.Patients with hypogonadism.
- •8.Patients with hypothyroidism.
- •9.Patients with other serious systemic diseases.
- •10.Spouse with serious systemic illness or pregnancy who is unable to cooperate.
- •11.Patients have taken any ED treatment medication within 1 month prior to study entry.
- •12.Patients are using other drugs related to the disease under study.
研究者
相似试验
进行中（未招募）
1 期
This is a study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD)Subjects with moderately to severely active Crohn's diseaseMedDRA version: 20.0Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-002869-18-BEAbbVie Deutschland GmbH & Co. KG265
进行中（未招募）
1 期
Clinical Trial to compare if seriously-ill adults with constipation due to narcotics have bowel movements sooner after injection with Methylnatrexone or placeboEUCTR2007-000854-30-BESalix Pharmaceuticals Inc254
进行中（未招募）
不适用
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 17.0Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861EUCTR2013-002343-29-GBRegeneron Pharmaceuticals, Inc.803
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease - E5555-G000-201Coronary Artery DiseaseMedDRA version: 8.1Level: PTClassification code 10011078EUCTR2005-006029-94-BEEisai Limited720
已完成
不适用
A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of JNJ-26070109abdominal pain and heartburn10017943NL-OMON30044Janssen-Cilag82